VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting BRAF(V600E) Mutation in Papillary Thyroid Cancer

Detection of BRAF(V600E) is useful for making diagnosis and risk stratification of papillary thyroid carcinoma (PTC). Molecular testing, however, is not always available for routine clinical use. To assess the clinical utility and reliability of VE1 immunohistochemistry (IHC) for detecting BRAF(V600...

Descripción completa

Detalles Bibliográficos
Autores principales: Choden, Sonam, Keelawat, Somboon, Jung, Chan Kwon, Bychkov, Andrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139976/
https://www.ncbi.nlm.nih.gov/pubmed/32150939
http://dx.doi.org/10.3390/cancers12030596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139976/
https://www.ncbi.nlm.nih.gov/pubmed/32150939
http://dx.doi.org/10.3390/cancers12030596

Ejemplares similares